Evidence map›Paper›PMID 41416928›Full record

ArticleEuropean journal of immunology2025

Hyperinflammation by Human Macrophages Induced by SARS-CoV-2 Anti-Spike IgG Is Dependent on Glucose and Fatty Acid Metabolism.

Chiara E Geyer, Luís Almeida, Lynn Mes, Frank Otto, W Ashwin Mak, Graham A Heieis, Jennifer Veth, Steven W de Taeye, Tom G Caniels, Tom P L Bijl and 8 more

Abstract read
In one paragraph

Article in European journal of immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Chiara E GeyerCenter for Infection and Molecular Medicine, Amsterdam institute for Immunology and Infectious diseases, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-9113-3292
Luís AlmeidaLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-8656-3135
Lynn MesCenter for Infection and Molecular Medicine, Amsterdam institute for Immunology and Infectious diseases, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-8807-7795
Frank OttoLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
W Ashwin MakCenter for Infection and Molecular Medicine, Amsterdam institute for Immunology and Infectious diseases, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands.
Graham A HeieisLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Jennifer VethCenter for Infection and Molecular Medicine, Amsterdam institute for Immunology and Infectious diseases, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands.
Steven W de TaeyeDepartment of Medical Microbiology, Amsterdam institute for Immunology and Infectious diseases, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands.
Tom G CanielsDepartment of Medical Microbiology, Amsterdam institute for Immunology and Infectious diseases, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands.
Tom P L BijlDepartment of Medical Microbiology, Amsterdam institute for Immunology and Infectious diseases, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands.
Marit J van GilsDepartment of Medical Microbiology, Amsterdam institute for Immunology and Infectious diseases, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands.
Menno de WintherDepartment of Medical Biochemistry, Experimental Vascular Biology, Amsterdam Cardiovascular Sciences, Amsterdam Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Amsterdam UMC COVID‐19 Biobank
Jan Van den BosscheDepartment of Molecular Cell Biology and Immunology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Hung-Jen ChenCenter for Infection and Molecular Medicine, Amsterdam institute for Immunology and Infectious diseases, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-6341-8170
Riekelt H HoutkooperLaboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Bart EvertsLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-3764-5131
Jeroen den DunnenLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-7199-8619

Funding

AGEM matching 2020AMC Fellowship 2015Amsterdam Infection and Immunity COVID-19 24184European Union's Horizon 2020 research and innovation programme 847551Innovative Medicines Initiative 2 Joint Undertaking 831434ZonMw 10430 01 201 0008
6 · The paper itself

Abstract

Severe COVID-19 is an immunological disorder characterized by excessive immune activation following infection with SARS-CoV-2, which typically occurs around the time of seroconversion. Anti-spike IgG of critically ill COVID-19 patients induces excessive inflammation by activation of Fc gamma receptors (FcγRs) on human alveolar macrophages, leading to tissue damage, pulmonary edema, and coagulopathy. While metabolic reprogramming of immune cells is critical for the induction of inflammatory responses, still little is known about the metabolic pathways that are involved in COVID-19-specific hyperinflammation. In this study, we identified that anti-spike IgG immune complexes (ICs) induce rapid metabolic reprogramming of alveolar macrophages, which is essential for the induction of inflammation. Through functional inhibition, we identified that glycolysis, fatty acid synthesis, and pentose phosphate pathway (PPP) activation are critical for anti-spike IgG-induced hyperinflammation. Remarkably, while excessive proinflammatory cytokine production by macrophages is critically dependent on simultaneous stimulation with viral stimuli and anti-spike IgG complexes, we show that the required metabolic reprogramming is specifically driven by anti-spike IgG complexes. These findings provide new insights into the metabolic pathways driving hyperinflammation by macrophages in the context of severe COVID-19. Targeting of these pathways may reveal new possibilities to counteract pathological inflammatory responses in severe COVID-19 and related diseases.

Indexed as

Antibodies, ViralCOVID-19Fatty AcidsGlucoseImmunoglobulin GInflammationMacrophagesMacrophages, AlveolarSARS-CoV-2Spike Glycoprotein, CoronavirusAntigen-Antibody ComplexCytokinesGlycolysisHumansPentose Phosphate PathwayReceptors, IgGAntibodies, ViralAntigen-Antibody ComplexCytokinesFatty AcidsGlucoseImmunoglobulin GReceptors, IgGSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2antibodiesCOVID‐19immunometabolismmacrophage

Identifiers

PMID41416928
PMCPMC12716191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.